ARCHIVES

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

This article is from The Cancer Letter archive.

Vol. 04 No. 36 | September 8, 1978

Download PDF Visit The Full Archive

Related Articles

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

June 14, 2013

NCCS Networker Volume 8 Issue 3, Fall 1994

September 12, 1994

Reed To Leave NCI Next Year; Allegra Moves To Extramural Side; Ozer Heads Okla. Center.

July 21, 2000

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

May 18, 2007

James Doroshow Named NCI Deputy Director, Clinical Research

June 10, 2011

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007